Danimer Scientific Announces Third Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- Nvidia forecasts quarterly revenue above estimates, shares rise
- Oil settles down after choppy session as investors weigh Hormuz talks
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
- NVIDIA (NVDA) Tops Q2 EPS by 14c, Offers Guidance
Danimer Scientific (DNMR) PT Lowered to $30 at Jefferies
November 16, 2021 8:17 AM ESTJefferies analyst Laurence Alexander lowered the price target on Danimer Scientific (NYSE: DNMR) to $30.00 (from $34.00) while maintaining a Buy rating following Q3 results.
The analyst commented, "Q3 was light on sales, mostly due to softer PLA sales masking PHA blend sales ~4% above... More
Danimer Scientific (DNMR) Tops Q3 EPS by 16c
November 15, 2021 4:24 PM ESTDanimer Scientific (NYSE: DNMR) reported Q3 EPS of $0.08, $0.16 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $13.4 million versus the consensus estimate of $14.56 million.
Business Outlook:
The Company expects to continue its acceleration of investments... More
